XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Sep. 30, 2021
Current Assets:    
Cash and cash equivalents $ 20,074 $ 31,153
Available-for-sale securities 2,012 7,717
Accounts receivable, net of allowances of $84 and $119 as of June 30, 2022 and September 30, 2021, respectively 9,382 9,169
Contract assets — royalties and license fees 7,584 7,091
Inventories, net 10,926 6,760
Income tax receivable 2,409 1,912
Prepaids and other 7,648 6,453
Total Current Assets 60,035 70,255
Property and equipment, net 28,289 30,090
Available-for-sale securities   2,002
Deferred income taxes 8,479 5,867
Intangible assets, net 30,752 37,054
Goodwill 42,590 45,606
Other assets 5,507 3,718
Total Assets 175,652 194,592
Current Liabilities:    
Accounts payable 1,928 1,783
Accrued liabilities:    
Compensation 7,595 8,480
Accrued other 5,857 4,905
Short-term borrowings 10,000 10,000
Deferred revenue 4,007 4,647
Total Current Liabilities 29,387 29,815
Deferred revenue, less current portion 7,402 10,301
Deferred income taxes 2,227 2,742
Other long-term liabilities 11,524 11,649
Total Liabilities 50,540 54,507
Commitments and Contingencies (Note 10)
Stockholders’ Equity:    
Series A Preferred stock — $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock — $.05 par value, 45,000 shares authorized; 13,999 and 13,899 shares issued and outstanding as of June 30, 2022 and September 30, 2021, respectively 700 695
Additional paid-in capital 26,612 21,598
Accumulated other comprehensive (loss) income (5,719) 1,727
Retained earnings 103,519 116,065
Total Stockholders’ Equity 125,112 140,085
Total Liabilities and Stockholders’ Equity $ 175,652 $ 194,592